The cellular signalling pathway that leads to activation of the NF-κB protein has been studied for many years, and one might think that there's little left to learn. But it still has some surprises in store.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y.-T. & Gaynor, R. B. Nature 423, 655–659 (2003).
Anest, V. et al. Nature 423, 659–663 (2003).
Ghosh, S. & Karin, M. Cell 109, S81–S96 (2002).
Strahl, B. D. & Allis, C. D. Nature 403, 41–45 (2000).
Cheung, P., Allis, C. D. & Sassone-Corsi, P. Cell 103, 263–271 (2000).
Hu, Y. et al. Nature 410, 710–714 (2001).
Li, X. et al. J. Biol. Chem. 277, 45129–45140 (2002).
Li, Q. T. et al. Genes Dev. 13, 1322–1328 (1999).
Saccani, S., Pantano, S. & Natoli, G. J. Exp. Med. 193, 1351–1359 (2001).
Zhong, H., May, M. J., Jimi, E. & Ghosh, S. Mol. Cell 9, 625–636 (2002).
Cao, Y. et al. Cell 107, 763–775 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Israël, A. A regulator branches out. Nature 423, 596–597 (2003). https://doi.org/10.1038/423596a
Issue Date:
DOI: https://doi.org/10.1038/423596a
This article is cited by
-
The IKK NF-κB system: a treasure trove for drug development
Nature Reviews Drug Discovery (2004)
-
Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers
The EMBO Journal (2004)